0001209191-21-000518.txt : 20210104 0001209191-21-000518.hdr.sgml : 20210104 20210104190012 ACCESSION NUMBER: 0001209191-21-000518 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20210101 FILED AS OF DATE: 20210104 DATE AS OF CHANGE: 20210104 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Enyedy Mark J CENTRAL INDEX KEY: 0001586965 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38707 FILM NUMBER: 21503348 MAIL ADDRESS: STREET 1: C/O FATE THERAPEUTICS, INC. STREET 2: 3535 GENERAL ATOMICS COURT, SUITE 200 CITY: SAN DIEGO STATE: CA ZIP: 92121 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: LogicBio Therapeutics, Inc. CENTRAL INDEX KEY: 0001664106 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 471514975 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 65 HAYDEN AVE STREET 2: 2ND FLOOR CITY: LEXINGTON STATE: MA ZIP: 02421 BUSINESS PHONE: 617-245-0399 MAIL ADDRESS: STREET 1: 65 HAYDEN AVE STREET 2: 2ND FLOOR CITY: LEXINGTON STATE: MA ZIP: 02421 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2021-01-01 0 0001664106 LogicBio Therapeutics, Inc. LOGC 0001586965 Enyedy Mark J 65 HAYDEN AVENUE, FLOOR 2 LEXINGTON MA 02421 1 0 0 0 Common Stock 2021-01-01 4 M 0 2921 A 2921 D Restricted Stock Units 2021-01-01 4 M 0 2921 0.00 D Common Stock 2921 0 D Each restricted stock unit ("RSU") represented a contingent right to receive one share of common stock of LogicBio Therapeutics, Inc. (the "Company"). All of the RSUs vested on January 1, 2021, subject to the terms and conditions of the award and the Company's 2018 Plan. Jonathan Quick, as Attorney-in-Fact 2021-01-04